Answers are grounded in this paper and cite their sources.
Both treatment protocols prevented rejection for the duration of the treatment in most animals. Blocking costimulation by anti-CD40 or by anti-CD40 plus anti-CD86 may be an effective method to prevent graft rejection and may obviate the need for other immunosuppressive drugs, especially in the immediate posttransplantation period.
No takes yet. Share an insight, caveat, or question.
Haanstra et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: